Study With Various Immunotherapy Treatments in Participants With Lung Cancer
Clinical trial NCT05676931 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05676931
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-21
- Primary completion
- 2027-12-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.